BioNTech (BNTX) News Today $111.66 +1.61 (+1.46%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$111.40 -0.26 (-0.23%) As of 04:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period BioNTech ADR Earns Relative Strength Rating UpgradeJuly 1, 2025 | msn.comInstil Bio: Chasing After Summit And BioNTech, Albeit With Some HiccupsJune 30, 2025 | seekingalpha.comRobeco Institutional Asset Management B.V. Sells 23,873 Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX)June 30, 2025 | marketbeat.comResearch Analysts Set Expectations for BioNTech Q3 EarningsJune 29, 2025 | americanbankingnews.comHC Wainwright Has Pessimistic View of BioNTech Q3 EarningsJune 29, 2025 | americanbankingnews.comWhat is HC Wainwright's Forecast for BioNTech Q3 Earnings?June 29, 2025 | marketbeat.comHC Wainwright Has Bearish Forecast for BioNTech Q3 EarningsJune 27, 2025 | marketbeat.comPfizer and BioNTech’s New Shingles Vaccine Study: What Investors Need to KnowJune 26, 2025 | msn.comHC Wainwright Has Optimistic Outlook of BioNTech Q2 EarningsJune 26, 2025 | marketbeat.comBNTX - BioNTech SE ADR Dividends - MorningstarJune 25, 2025 | morningstar.comM3BNTX : Expert Outlook: BioNTech Through The Eyes Of 11 AnalystsJune 25, 2025 | benzinga.comHC Wainwright Reiterates Buy Rating for BioNTech (NASDAQ:BNTX)June 25, 2025 | marketbeat.com3,300 Shares in BioNTech SE Sponsored ADR (NASDAQ:BNTX) Purchased by Prosperity Wealth Management Inc.June 19, 2025 | marketbeat.comQ4 Earnings Forecast for BioNTech Issued By HC WainwrightJune 18, 2025 | marketbeat.comHC Wainwright Has Negative Outlook for BioNTech Q4 EarningsJune 17, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Price Target Cut to $138.00 by Analysts at HC WainwrightJune 16, 2025 | marketbeat.comBioNTech SE (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 15, 2025 | marketbeat.comSG Americas Securities LLC Has $3.52 Million Stake in BioNTech SE (NASDAQ:BNTX)June 14, 2025 | marketbeat.comStrategic Acquisition and Pipeline Synergies Drive Buy Rating for BioNTechJune 13, 2025 | tipranks.comCOVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer TreatmentsJune 12, 2025 | msn.comStock Movers: GameStop, BioNTech, OracleJune 12, 2025 | bloomberg.comBioNTech to Buy CureVac for $1.25 Billion to Boost Cancer ArmJune 12, 2025 | bloomberg.comBioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer TreatmentJune 12, 2025 | msn.comBioNTech to buy German rival CureVac for $1.25B in all-stock dealJune 12, 2025 | msn.comBioNTech's Acquisition Of CureVac Brings Complementary Method To Target CancerJune 12, 2025 | seekingalpha.comBioNTech boosts cancer mRNA pipeline with CureVac acquisitionJune 12, 2025 | proactiveinvestors.comBioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.June 12, 2025 | barrons.comBioNTech to acquire CureVac in $1.25 billion all-stock dealJune 12, 2025 | reuters.comBioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange OfferJune 12, 2025 | globenewswire.comGAMMA Investing LLC Buys 52,711 Shares of BioNTech SE (NASDAQ:BNTX)June 11, 2025 | marketbeat.comMerz hails BioNTech founders' 'courage' as they receive German prizeJune 10, 2025 | yahoo.comRFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts sayJune 10, 2025 | cnbc.comVaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-upJune 10, 2025 | reuters.comWhy Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.June 10, 2025 | barrons.comEquities Analysts Offer Predictions for BioNTech Q1 EarningsJune 9, 2025 | marketbeat.comTB Alternative Assets Ltd. Acquires Shares of 38,996 BioNTech SE (NASDAQ:BNTX)June 8, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Upgraded at Wall Street ZenJune 7, 2025 | marketbeat.comBristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better InvestmentJune 6, 2025 | seekingalpha.comHC Wainwright Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) StockJune 5, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Neuren Pharmaceuticals Limited (OtherNURPF), GlaxoSmithKline (GSK) and BioNTech SE (BNTX)June 5, 2025 | theglobeandmail.comStrategic Partnership with BMY Boosts BioNTech’s Oncology Prospects and Financial StabilityJune 4, 2025 | tipranks.comBioNTech's Deal With Bristol Myers Over BNT-327 May Be OverhypedJune 4, 2025 | seekingalpha.comIs BioNTech Stock a Buy on Major $11 Billion Cancer-Drug Deal?June 4, 2025 | theglobeandmail.com1BNTX : 12 Analysts Have This To Say About BioNTechJune 4, 2025 | benzinga.comTruist Lifts BioNTech (BNTX) Price Target After New PartnershipJune 4, 2025 | msn.comBioNTech SE (NASDAQ:BNTX) Shares Sold by Mackenzie Financial CorpJune 4, 2025 | marketbeat.comBristol Myers CEO explains why he’s spending billions on BioNTech dealJune 3, 2025 | msn.comBioNTech (NasdaqGS:BNTX) Enters Global Co-Development Agreement With Bristol Myers SquibbJune 3, 2025 | finance.yahoo.comBioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's WhyJune 3, 2025 | marketbeat.comBioNTech (NASDAQ:BNTX) Shares Gap Up - Time to Buy?June 3, 2025 | marketbeat.com Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BNTX Media Mentions By Week BNTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BNTX News Sentiment▼0.020.57▲Average Medical News Sentiment BNTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BNTX Articles This Week▼112▲BNTX Articles Average Week Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today Teva Pharmaceutical Industries News Today Insmed News Today Summit Therapeutics News Today Intra-Cellular Therapies News Today Genmab A/S News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BNTX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNTX Stock Alerts